¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Sodium Citrate and Citric Acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • tooth and nail syndrome
    ÀÌ ¼Õ¹ßÅé ÁõÈıº
  • tracts and fascicles of hypothalamus
    ½Ã»óÇϺÎÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
  • tracts and fascicles of thalamus
    ½Ã»óÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
  • trial and error
    ½ÃÇàÂø¿À(ãËú¼ó¹è¦)
  • trial and error
    ½ÃÇàÂø¿À(ãËú¼ó¹è¦).
  • trial-and-error learning
    ½ÃÇàÂø¿ÀÇнÀ(ãËú¼ó¹è¦æßã§).
  • tumor growth,cell cycle and
    ¼¼Æ÷ÁÖ±â¿Í ¡­
  • tumor immunity,gene therapy and
    À¯ÀüÀÚ Ä¡·á¿Í ¡­
  • ultrasonic and sonic vibration
    ÃÊÀ½ÆÄ-À½ÆÄÁøµ¿
  • vertigo, positional and postural
    µÎÀ§ ¹× üÀ§ º¯È¯(¼º) Çö±â
  • wagr syndrome (wilmstumor, aniridia, genital anomalies and mental retardation)
    WAGR ÁõÈıº(¡­ñøý¦ÏØ)
  • wear and tear
    ¼Ò¸ð(á¼ÙÄ)
  • wear and tear dermatitis
    ¹Ýº¹ÀÚ±Ø ÇǺο°
  • wear and tear pigment
    ¼Ò¸ð»ö¼Ò(¡­ßäáÈ).
  • wear and tear quota
    ¼Ò¸ðºÐ(á¼ÙÄÝÂ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • myristic acid
    ¹Ì¸®½ºÆ®»ê(ß«)
  • nalidixic acid
    ³¾¸®µñ»ê(ß«)
  • nervonic acid
    ³Êº»»ê(ß«)
  • neuraminic acid
    ´º¶ó¹Î»ê(ß«)
  • neutral amino acid
    Áß¼º(ñéàõ) ¾Æ¹Ì³ë»ê(ß«)
  • nicotinic acid
    ´ÏÄÚÆ¾»ê(ß«)
  • nicotinic acid amide
    ´ÏÄÚÆ¾»ê(ß«) ¾Æ¸¶À̵å
  • nitrous acid
    ¾ÆÁú»ê(ä¬òòß«)
  • nitrous acid mutant
    ¾ÆÁú»êº¯ÀÌü(ä¬òò߫ܨì¶ô÷)
  • nonionized acid
    ºñ(Þª)ÀÌ¿ÂÈ­(ûù) »ê(ß«)
  • nonnucleic acid base
    ºñÇÙ»ê ¿°±â(Þªú·ß«ç¤Ðñ)
  • nonpolar amino acid
    ¹«±Ø¼º(Ùíпàõ) ¾Æ¹Ì³ë»ê(ß«)
  • nonprotein amino acid
    ºñ´Ü¹éÁú(ÞªÓ±ÛÜòõ) ¾Æ¹Ì³ë»ê(ß«)
  • nucleic acid
    ÇÙ»ê(ú·ß«)
  • nucleic acid bases
    Çٻ꿰±â(ú·ß«ç¤Ðñ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
NUC nonspecific ulcerative colitis; sodium urate crystal
PBS perfusion-pressure breakthrough syndrome; phenobarbital sodium; phosphate-buffered saline; planar bo...
PNa plasma sodium
PSP pancreatic spasmolytic peptide; paralytic shellfish poisoning; parathyroid secretory protein; period...
SAGM sodium chloride, adenine, glucose, mannitol
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
CDCA Cholic acid , chenodeoxycholic acid
cicloxilic acid cis-2-Hydroxy-2-phenyl-cyclohexanecarboxilic acid
14C 1) [3H]cholesterol and
6-(14)C 2-(14)C]-glucose, and
(14)C 14)CO(2) and
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nissl's acid
    ´Ï½½»ê
    »ê¼º¾× ¶Ç´Â ¾Ï¸ð´Ï¾Æ¿¡ ³ì´Â´Ù.
  • nitrobenzoic acid
    ´ÏÆ®·Î ¾È½ÄÇâ »ê
    NO2C6H4COOH. ´ÏÆ®·Î Åç·ç¿ÃÀÌ »êÈ­µÇ¾î »ý±â´Â È­ÇÕ¹°.
  • nitroferrocyanic acid
    ´ÏÆ®·Î Æä·Î½Ã¾È»ê
    H2[Fe
  • octanoic acid
    ¿ÁÅ×Àλê
  • oleic acid
    ¿Ã·¹»ê
    µ¿½Ä¹°¿¡ ³Î¸® Á¸ÀçÇÏ´Â Áö¹æ»ê. È­ÇÐ½Ä C8H4O, ³ì´ÂÁ¡ 12 ¡É, ²ú´ÂÁ¡ 360 ¡ÉÀÌ´Ù. ÀÌÁß °áÇÕÀ» 1°³ °¡Áö´Â ºÒÆ÷È­ Áö¹æ»êÀÌ´Ù. ¹°¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª, ¿¡Åº¿Ã, ¿¡Å׸£, Ŭ·Î·ÎÆ÷¸§ µî¿¡´Â ³ì´Â´Ù. ¹é±ÝÈæ, ´ÏÄÌ µîÀ» Ã˸ŷΠÇÏ¿© ¼ö¼Ò·Î ȯ¿ø½ÃŰ¸é Æ÷È­ÀÎ ½ºÅ׾Ƹ£»êÀÌ µÈ´Ù. ¼ø¼öÇÑ °ÍÀº ¹«»ö, ¹«ÃëÀÎ À¯»ó ¾×üÀ̳ª, °ø±â ¼Ó¿¡ ¹æÄ¡ÇØ µÎ¸é »êÈ­µÇ¾î Ȳ»ö ¶Ç´Â °¥»öÀ¸·Î Âø»öµÇ°í ½â´Â ³¿»õ°¡ ³­´Ù. µ¿¹°¿¡¼­´Â ±Û¸®¼¼¸°°ú ¿¡½ºÅ׸£¸¦ Çü¼ºÇÏ¿© ÇÇÇÏ Áö¹æÀ̳ª °£¿¡ ÀúÀåµÈ´Ù. °ø¾÷ÀûÀ¸·Î ¿ëµµ°¡ ³ÐÀ¸¸ç, ºñ´©ÀÇ ¿ø·á³ª õÀÇ ¹æ¼öÁ¦·Î¼­ ÀÌ¿ëµÈ´Ù.
  • ophthalmic acid
    ¿ÀÇÁÅ»¹Î»ê
    ¼ÒÀÇ ¼öÁ¤Ã¼ Áß¿¡ Á¸ÀçÇÏ´Â Æ®¶óÀÌ ÆéŸÀ̵å.
  • organic acid
    À¯±â»ê
    1. ¿øÀÚ´ÜÀÌ Åº¼Ò À¯µµÃ¼ÀÎ »ê. źȭ¼ö¼Ò±â°¡ COOH³ª SO3H¿Í °áÇÕÇϰí ÀÖ´Â È­ÇÕ¹°. 2. »ê¼ºÀ» ¶ì´Â À¯±âÈ­ÇÕ¹°ÀÇ ÃÑĪ. ¹«±â»ê°ú ´ëÀÀÇÏ´Â ¸»·Î¼­ ¾Æ¼¼Æ®»ê, ºÎƼ¸£»ê, ÆÈ¹ÌÆ®»ê, ¿Á»ì»ê, Ÿ¸£Å¸¸£»ê µîÀÌ ÀÖ´Ù. ±× ´ëºÎºÐÀº Ä«¸£º¹½Ã»êÀ̹ǷΠÁ¼Àº ¶æÀ¸·Î´Â Ä«¸£º¹½Ã»êÀ» °¡¸®Å²´Ù. ±×·¯³ª ¾Æ½ºÄÚ¸£ºê»êÀ̳ª ¿ä»ê
  • oxalacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • pantotheic acid
    ÆÇÅäÅÙ»ê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • para- : ºÎ, ÁÖÀ§, ¹æ, ±Ù, ±Ù»ç, ¿ø ¹× ÀÌ µîÀÇ ¶æÀ» ³ªÅ¸³»´Â Á¢µÎ¾î.

    para-amino salicylic acid

    ÆÄ¶ó-¾Æ¹Ì³ë »ì¸®½Ç »ê
    ÇÕ¼ºµÈ Ç×°áÇÙ ¾àÀ¸·Î Ç×±Õ ÀÛ¿ëÀº °áÇÙ ±Õ¿¡ ƯÀÌÀûÀÌ¸ç ´Ù¸¥ º´¿ø ±Õ¿¡ ÀÛ¿ëÇÏÁö ¾Ê´Â´Ù. È­ÇÐ ±¸Á¶´Â »ì¸®½Ç »ê°ú À¯»çÇϳª ÁßÃß ½Å°æ°è¿¡ ´ëÇÑ ÀÛ¿ëÀº °ÅÀÇ ¾ø´Ù. ÀÛ¿ë ±âÀüÀº ¸íÈ®ÇÏÁö ¾ÊÀ¸¸ç ´ë»ç ±æÇ×Á¦, È£Èí »ê¼Ò ÀúÇØ¼³ÀÌ ÀÖ´Ù. ½ÃÇè°ü ³»ÀÇ Ç×±Õ ÀÛ¿ëÀº °­ÇÏÁö¸¸ Ç׿°Àº ¾ÆÀ̼ҳªÀ̾ÆÁö, ½ºÆ®·¾Å丶À̽ź¸´Ù ¾à°£ ¾àÇÏ¸ç ´ë·®ÀÇ º¹¿ëÀ» ¿äÇÑ´Ù. ½ºÆ®·¾Å丶À̽ź¸´Ù ³»¼º ÃâÇöÀÌ ´Ê´Ù. ´Üµ¶º¸´Ù ½ºÆ®·¾Å丶À̽Å, ¾ÆÀ̼ҳªÀ̾ÆÁöµå¿ÍÀÇ º´¿ëÀº È¿°ú Áõ°­°ú ³»¼º ¹ßÇöÀÇ Áö¿¬È­¸¦ ³ë¸°´Ù. µ¶¼ºÀº ÀÛÀ¸¸ç ºÎÀÛ¿ëÀÇ ÁÖµÈ °ÍÀº ¼ÒÈ­°ü¿¡ ´ëÇÑ ±¹¼Ò Àڱؿ¡ ÀÇÇÑ °Í
  • paraaminohippuric acid
    ÆÄ¶ó ¾Æ¹Ì³ë¸¶´¢»ê, ÆÄ¶ó ¾Æ¹Ì³ëÈ÷Ǫ¸£»ê
    ¾Æ¹Ì³ë ¾È½ÄÇâ»êÀÇ N-ÃÊ»ê. C
  • pentonic acid
    ÆæÅæ»ê
  • performic acid
    °úÀÇ»ê
    cysteinÀ» »êÈ­ÇÏ¿© cysteic acid·Î ÇÏ¿© ÆéŸÀ̵åÀÇ disulfide °áÇÕÀ» Âɰ³±â À§ÇÏ¿© »ç¿ëµÇ´Â À¯±â°ú»ê¼Ò»ê.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
tetraiodophenolphthalein sodium A radiographic contrast medium. The disodium salt was once used in radiography of the gallbladder.
Synonym: tetraiodophenolphthalein sodium.
(05 Mar 2000)
theophylline sodium acetate A mixture of theophylline sodium and sodium acetate, with 60% of theophylline; has the same uses as theophylline.
(05 Mar 2000)
theophylline sodium glycinate Equilibrium mixture containing theophylline sodium and glycine in approximately molecular proportions, buffered with an additional mole of glycine; similar in action and uses to aminophylline but more stable in air, and less irritating to the gastric mucosa.
(05 Mar 2000)
thiamylal sodium Sodium 5-allyl-5-(1-methylbutyl)-2-thiobarbiturate;a short-acting barbiturate, prepared as a mixture with sodium bicarbonate, used intravenously to produce anaesthesia of short duration.
(05 Mar 2000)
thiopental sodium Sodium 5-ethyl-5-(1-methylbutyl)-2-thiobarbiturate;an ultra-short-acting barbiturate administered intravenously or rectally for induction of anaesthesia.
(05 Mar 2000)
thyroxine sodium A preparation obtained by the action of a limited amount of sodium carbonate upon thyroxine; it contains between 61 and 65% of iodine.
See: sodium levothyroxine, sodium liothyronine.
(05 Mar 2000)
effervescent sodium phosphate Exsiccated sodium phosphate 200, sodium bicarbonate 477, tartaric acid 252, and citric acid 162, mixed and passed through a sieve to make a granular salt.
(05 Mar 2000)
estramustine phosphate sodium Estra-1,3,5(10)-triene-3,17-diol(17b)-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt;an antineoplastic agent that combines the actions of oestrogen and nitrogen mustard in the treatment of carcinoma of the prostate.
(05 Mar 2000)
ethacrynate sodium Sodium salt of ethacrynic acid for parenteral use.
(05 Mar 2000)
tyropanoate sodium 3-Butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamic acid, sodium salt;an oral contrast medium for cholecystography.
(05 Mar 2000)
exsiccated sodium sulfite Anhydrous sodium sulfite, used as a preservative in pharmaceutical preparations.
(05 Mar 2000)
zomepirac sodium Sodium 5-(p-chlorodoenzoyl)-1,4-dimethylpyrrole-2-acet ate dihydrate;an analgesic anti-inflammatory agent, no longer marketed.
(05 Mar 2000)
fluorescein sodium A dye used for diagnosis of certain ocular diseases, differentiation or delineation of organ parts in surgery, and determination of circulation time.
Synonym: resorcinolphthalein sodium, uranin.
(05 Mar 2000)
fusidate sodium The sodium salt of fusidic acid; has antibacterial properties.
Synonym: sodium fusidate.
(05 Mar 2000)
low sodium syndrome <syndrome> A syndrome resulting from salt restriction and use of diuretics in treatment of congestive heart failure and hypertension, characterised by weakness, drowsiness, muscle cramps, and a reduction in glomerular filtration with consequent nitrogen retention, renal failure, and sometimes death; occurs also in cirrhosis of the liver with ascites and in adrenal insufficiency.
Synonym: salt depletion syndrome.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á